Compare ARDX & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARDX | NEOG |
|---|---|---|
| Founded | 2007 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2014 | 1989 |
| Metric | ARDX | NEOG |
|---|---|---|
| Price | $5.80 | $6.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 4 |
| Target Price | ★ $10.65 | $8.83 |
| AVG Volume (30 Days) | 2.7M | ★ 3.3M |
| Earning Date | 10-30-2025 | 01-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $398,234,000.00 | ★ $886,886,000.00 |
| Revenue This Year | $22.71 | N/A |
| Revenue Next Year | $27.81 | $1.80 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 58.12 | N/A |
| 52 Week Low | $3.21 | $3.87 |
| 52 Week High | $6.78 | $13.51 |
| Indicator | ARDX | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 53.23 | 60.59 |
| Support Level | $5.73 | $5.82 |
| Resistance Level | $6.20 | $6.08 |
| Average True Range (ATR) | 0.29 | 0.31 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 57.78 | 91.93 |
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.